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Abstract
Practice guidelines are important tools for improving the delivery of evidence-based practices and
reducing inappropriate variation in current treatment approaches. This study examined the degree
to which guidelines targeted to the treatment of substance use disorders or serious mental illness
address treatment of co-occurring disorders. Guidelines archived by the National Guideline
Clearinghouse (NGC) were retrieved in December 2007 and content analyzed. Nineteen pertinent
guidelines were identified, and 11 included recommendations regarding the assessment and/or
treatment of co-occurring disorders. None of the guidelines making recommendations for
treatment of co-occurring disorders included outcomes that clearly targeted both substance use and
mental health disorders. Limitations and implications of this study are noted.
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Introduction
Substance use disorders (SUDs) and serious mental illnesses (SMIs) are significant public
health concerns. Approximately 22 million people in the United States were classified with
substance use or dependence in the past year (Epstein, Barker, Vorburger, and Murtha,
2004) and 44 million people have experienced a SMI within the past year (National Institute
of Mental Health, 2001; US Department of Health and Human Services, 1999).
Furthermore, the Substance Abuse and Mental Health Services Administration (SAMHSA)
estimated in 1997 that the United States expended roughly $85 billion for these disorders,
and 56% of this amount was from public sources in that year alone (Mark, 2003; Mark et al.,
2000).
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Substance use disorders and serious mental illnesses frequently co-occur. According to the
US Surgeon General, 41 to 65% of persons with a lifetime SUD also have a history of at
least one SMI, and approximately 50% of persons with a lifetime SMI also have a lifetime
history of at least one SUD (US Department of Health and Human Services, 1999).
Therefore, a maxim of contemporary epidemiological and services research is that co-
occurring disorders (also referred to as “comorbidity” and “dual diagnosis”) are the rule
rather than the exception (Stinson et al., 2005).
According to Drake and colleagues (2001), staged interventions, assertive outreach,
motivational interventions, counseling, social support, a long-term perspective,
comprehensiveness, and cultural sensitivity and competency are the key components of
effective treatment for co-occurring disorders. Despite evidence that existing treatment
approaches can be effective (Brunette, Mueser, and Drake, 2004; Drake, Mercer-McFadden,
Cueser, McHugo, and Bond, 1998; Drake, Mueser, Brunette, and McHugo, 2004; Dumaine,
2003; RachBeisel, Scott, and Dixon, 1990), only a small percentage of people with co-
occurring disorders receive effective treatment that addresses both disorders (Substance
Abuse and Mental Health Services Administration, 2002; Watkins, Burnam, Kung, and
Paddock, 2001). This lamentable state of affairs may be attributable to the absence of brief
screening instruments (Lincoln, Liebschutz, Chernoff, Nguyen, and Amaro, 2006; Swartz
and Lurigio, 2006), which are critical for recognizing and subsequently treating disorders.
Services research has also documented limited availability of services targeting co-occurring
disorders (Ducharme, Knudsen, and Roman, 2006; Watkins et al., 2001), and absence of
training vis-à-vis assessment and treatment of comorbid conditions (Hall, Amodeo, Shaffer,
and Vander Bilt, 2000). Given the high costs and deleterious consequences of co-occurring
SUDs and SMIs, numerous governmental agencies have made quality improvement in this
practice area a priority (National Advisory Mental Health Council, 1999; National Institute
of Drug Abuse, 2003; President's New Freedom Commission on MentalHealth, 2002; US
Department of Health and Human Services, 2000).
The emergence of translational research is a direct result of increased awareness of the
pressing need to improve the system of care for dually diagnosed clients. Treatment
guidelines are important components of broader strategies for moving research into practice
and changing provider practice patterns (Grimshaw et al., 2001, 2004). Treatment guidelines
are the systematically compiled statements of empirically tested knowledge and
recommended practices designed to help practitioners and clients select appropriate
interventions for specific clinical circumstances (Proctor and Rosen, 2003; Rosen and
Proctor, 2003). A key function of guidelines is to promote effective decision-making in
situations that are frequently encountered by service providers and their clients (Eddy,
1996). Clinical practice guidelines have received considerable attention in the literature on
evidence-based practices and are one of the major tools for reducing treatment variability
and translating research into practice (Howard and Jensen, 1999; Institute of Medicine,
2006; Rosen and Proctor, 2003; Walker, Howard, Lambert, and Suchinsky, 1994; Walker,
Howard, Walker, Lambert, and Suchinsky, 1995).
Research Objectives
Using a public open-access database of treatment guidelines, this study examined the extent
to which current guidelines targeting either SUDs or SMIs also addressed co-occurring
disorders. Co-occurring disorders are associated with a wide range of problems requiring the
attention of service providers from various disciplines. Therefore, this study also examined
the outcomes and intended audience targeted in guidelines that address co-occurring SUDS
and SMIs.
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This study examined guidelines archived by the National Guideline Clearinghouse (NGC;
http://www.guidelines.gov/), which is a public, open-access database of treatment
guidelines. The NGC is sponsored by the Agency for Healthcare Research and Quality
(AHRQ) of the US Department of Health and Human Services. It was originally created by
AHRQ in partnership with the American Medical Association and the American Association
of Health Plans (now America's Health Insurance Plans). Advantages of this resource are
that guidelines are presented in a standardized format, located in a single database, and
freely available, thereby reducing the burden of searching for and retrieving guidelines. The
NGC is the only coordinated effort to organize and disseminate practice guidelines in this
fashion. This database also contains guidelines produced by the major health-related
organizations, including the American Medical Association, the American Psychiatric
Association, and the Department of Veterans Affairs. At the time of writing this report, the
database included 2,264 guidelines.
Search Definitions
In this study, “substance use disorders” included abuse or dependence based on the criteria
of the DSM-IV-TR (American Psychiatric Association, 2000). “Substances” of abuse were
alcohol and those psychoactive drugs identified in DSM-IV-TR (Brunette et al., 2004). The
specific SMIs targeted in this study were those associated with significant disability and that
were widely prevalent and commonly treated within the public mental health system:
schizophrenia-spectrum disorders, bipolar disorder, and major depression (Drake et al.,
2001).
“Co-occurring disorders” referred to the simultaneous presentation of a substance use
disorder and a serious mental illness. This usage is synonymous with other commonly used
terms such as “dual diagnosis,” “dual disorders,” “co-morbidity,” and “coexisting
disorders.”
Search Procedures
A computerized bibliographic search for guidelines of the NGC database was conducted on
December 1, 2007. The NGC database does not provide the facilities to conduct complex
searches containing Boolean operators. Thus, the procedure involved a broad-based search
using the following key words: “substance abuse,” “bipolar disorder,” “depression,” and
“schizophrenia.” This search procedure proved to be comprehensive. Specifically, it
returned guidelines that were relevant to the study purpose and numerous guidelines that
were irrelevant. The search strategy also returned a large number of duplicate guidelines.
For example, the search for schizophrenia guidelines returned many depression guidelines.
Subsequent searches using other synonymous keywords (e.g., major depressive disorder,
psychosis, schizoaffective disorder, substance dependence, drug abuse) did not return
additional unique guidelines. Finally, a search for guidelines targeting “co-occurring
disorders” and its various synonyms (e.g., dual diagnosis, dual disorders, co-morbidity, and
coexisting disorders) did not produce any additional unique guidelines.
A preliminary review indicated that the available guidelines for SUDs and SMIs were very
heterogenous, targeting a variety of different populations and multiple disorders. In order to
produce a set of guidelines that were comparable with respect to study aims, a set of
inclusion and exclusion criteria was applied. Each criterion and the number of guidelines
excluded at each step are summarized in Table 1. The criteria and justification are as
follows. Guidelines were limited to adult treatment (age 17 to 44 years), given the
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prevalence of the disorders and treatment varies considerably with different age groups.
Guidelines were excluded if they were not published by a US organization, since the system
of care can largely determine the treatment possibilities. Guidelines were also excluded if
they did not specifically address the target SUDs or SMIs as primary disorders. For
example, guidelines were excluded that considered SUDs or SMIs as secondary conditions
associated with other primary medical or social conditions (e.g., spinal cord injury,
cardiovascular disease, and domestic violence). As this study focused on interdisciplinary
guidelines, guidelines focusing specifically on medication management were also excluded
from the review.
After excluding duplicate guidelines, the complete guidelines were downloaded as portable
document files (PDFs) and reviewed. The full list of search results was compiled and the
titles and summaries of each guideline were reviewed.
Coding
Guidelines were examined to determine whether they provided any treatment or screening
recommendations regarding co-occurring disorders. Treatment recommendations included
any clinical or psychosocial interventions specifically targeting co-occurring disorders.
Screening recommendations included any diagnostic or assessment procedures for co-
occurring disorders. Intended users of guidelines were categorized into two types: (1)
medical professionals (physicians, nurses, advanced practice nurses, pharmacists, physician
assistants, and other health care providers); (2) behavioral health clinicians (social workers,
psychologists, other mental health professionals, and substance use disorder treatment
providers). The different types of major outcomes targeted by each treatment guideline were
recorded as written.
Results
Recommendations for Co-Occurring Disorders
A total of 19 unique treatment guidelines were retrieved from the NGC database; nine
guidelines targeted SUDs and 10 targeted SMIs. These guidelines and their full citations are
provided in Appendix purposes of brevity, guidelines cited in the text are referred to by the
letter preceding the abbreviation in this Appendix.
Of the total guidelines, slightly more than half (58%, N = 11) contained at least one
recommendation with respect to assessment and/or treatment of co-occurring disorders (see
Table 2). While SMI guidelines had a higher proportion of co-occurring recommendations
than SUD guidelines (64% versus 55%, respectively), these differences were not significant
based on a Fisher's exact test (p = .41). Bipolar disorder was the only type of disorder for
which there were no guidelines containing recommendations for a co-occurring disorder.
Across all guidelines that addressed co-occurring disorders, the most common
recommendation was for screening/assessment, which was present in 64% (N = 7) of the
guidelines (Guidelines D, B, G, H, M, O, P, Q). Forty-five (N = 5) of the guidelines
recommended a referral to a provider in the other (i.e., SUD or SMI) sector of care
(Guidelines G, M, O, P, R). Four guidelines recommended collaboration or cooperation
across sectors (Guidelines C, B, G, O), and one guideline recommended integrated SUD and
SMI treatment (Guideline R). It should be noted that two guidelines recommended
“treatment” (Guidelines H, Q), but additional information was not specified in terms of how
treatment should be conducted (e.g., collaboratively or in an integrated approach).
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Medical professionals were the intended users of all 11 treatment guidelines that addressed
co-occurring disorders. Of these 11 guidelines, all but three (Guidelines O, Q, R) also listed
behavioral health professionals as intended users. Specifically, all guidelines for SUDs that
included recommendations for co-occurring disorders targeted both medical and behavioral
health providers. However, behavioral health providers were not listed as intended users on
two SMI guidelines for depression guidelines (Guideline O, Q) and one SMI guideline for
schizophrenia/psychosis (Guideline R).
Treatment Outcomes
With the exception of one (Guideline O), all guidelines listed treatment outcomes. The
number of outcomes targeted in these guidelines containing recommendations for co-
occurring disorders ranged from 3 to 11 (Mean = 5.9, SD = 3.0). Among this set of
guidelines, there were no clear outcomes that addressed both psychiatric symptomatology
and substance abuse-related outcomes, such as relapse. Three SMI guidelines that addressed
co-occurring disorders in some fashion referred to relapse (Guidelines M, P, S) but did not
indicate whether relapse referred to the SMI, SUD, or both. All guidelines that addressed co-
occurring disorders and described treatment outcomes targeted at least one psychosocial
outcome beyond clinical outcomes.
Discussion
This study reviewed the degree to which guidelines for SMIs and SUDs archived by the
National Guidelines Clearinghouse addressed treatment for co-occurring disorders. Slightly
more than half of the total guidelines retrieved included some type of recommendation for
the treatment of co-occurring disorders. These recommendations included assessment,
referrals, and collaboration with other professionals in the other sector of care. With the
exception of two guidelines (described below), these recommendations contained minimal
elaboration or specificity, leaving considerable room for interpretation on how the
recommendations should actually be implemented in routine practice.
Two guidelines are particularly noteworthy with respect to their specificity regarding
treatment for co-occurring disorders. This included the treatment guideline for
schizophrenia, authored by the American Psychiatric Association (Guideline R). This
guideline provided a comprehensive description of the major features of treatment (e.g., case
management, family interventions, rehabilitation, pharmacotherapy, and housing) and noted
the importance of the same clinicians treating both the SMI and SUD. Overall, these
recommendations are consistent with the broader literature on comprehensive and integrated
treatment for this population (Drake et al., 1998, 2001). It should be noted that the treatment
guideline for bipolar disorder, also authored by the American Psychiatric Association
(Guideline J), did not contain any treatment recommendations regarding SUDs. This is a
surprising finding, given the evidence suggesting that the rates of co-occurring alcohol and
drug problems among persons with bipolar disorder are at least equal to or greater than the
rates among persons with schizophrenia (Robins and Regier, 1991).
The second guideline to address treatment targeted substance use disorders with co-
occurring psychiatric disorders (Guideline B). This is a comprehensive treatment guideline
that contains screening suggestions, essential components of treatment (e.g., psychoe-
ducation, double trouble groups, and community-based dual recovery mutual self-help
groups), and treatment strategies (e.g., motivational interviewing, contingency management,
relapse prevention, and assertive community treatment). This guideline also corresponds to a
larger treatment manual provided by the Center for Substance Abuse Treatment (2005).
Perron et al. Page 5













The majority of the guidelines targeting co-occurring disorders were intended for a
multidisciplinary audience of service providers. This reflects the wide recognition that
treating SUDs, SMIs, and these conditions as they co-occur requires coordination with many
different provider types. However, the outcomes targeted by the guidelines were generally
restricted to the primary focus of the single disorder, even though the assessment and/or
treatment issues addressed co-occurring disorders. This suggests that many of these
guidelines have limited utility for addressing the full range of problems and needs that are
commonly encountered among persons with co-occurring disorders.
Limitations and Generalizability
This systematic review was restricted to guidelines archived on the NGC. This excluded a
potentially large number of proprietary and nonproprietary guidelines that are available in
print and electronically. Thus, the generalizability of this study is limited. Additionally, it
was beyond the scope of this study to examine the quality and consistency of the
recommendations contained in the guidelines against the extant literature. Despite these
limitations, it is important to emphasize that the NGC remains as one of the largest (or the
largest) data base that provides readily obtainable guidelines from major organizations that
are free.
Conclusions
Treatment guidelines can play an important role in implementing evidence-based practices
and changing provider practice patterns. Two guidelines that provide very specific
information for treating co-occurring disorders were located. Although the current
guidelines are limited, the NGC provides an infrastructure that makes guidelines widely
available without charge. Additional efforts are needed to improve existing guidelines to
better address co-occurring disorders. Without such guidelines, practitioners may fail to
screen for and identify the presence of co-occurring SUDs and SMIs. Furthermore, in
addition to screening, comprehensive empirically based treatment guidelines are necessary
to inform practitioners of integrated treatment methods. As existing research suggests,
outcomes for primary presenting disorders are likely to be improved through proper
screening and treatment (Baethge et al., 2005; Haywood et al., 1995; Mangrum, Spence, and
Lopez, 2006; Sacks, McKendrick, Sacks, Banks, and Harle, 2007). Additional research is
also needed to better understand and overcome barriers related to the implementation of
treatment guidelines and other forms of evidence-based practice (see Grimshaw, Eccles, and
Tetroe, 2004).
Appendix
Treatment Guidelines Included in a Systematic Review
Abbreviation Full citation
Substance use disorders
A. APA (2006a) Work Group on Substance Use Disorders, Kleber HD, Weiss RD, Anton RF, Rounsaville BJ,
George TP, Strain EC, Greenfield SF, Ziedonis DM, Kosten TR, Hennessy G, O'Brien CP,
Connery HS, American Psychiatric Association Steering Committee on Practice Guidelines,
McIntyre JS, Charles SC, Anzia DJ, Nininger JE, Cook IA, Summergrad P, Finnerty MT,
Woods SM, Johnson BR, Yager J, Pyles R, Lurie L, Cross CD, Walker RD, Peele R, Barnovitz
MA, Gray SH, Shemo JP, Saxena S, Tonnu T, Kunkle R, Albert AB, Fochtmann LJ, Hart C,
Regier D. Treatment of patients with substance use disorders (2nd ed.). American Psychiatric
Association, Washington, DC. Am J Psychiatry (2006 Aug); 163(8 Suppl):5–82.
B. CSAT (2005) Center for Substance Abuse Treatment. (2005). Substance abuse treatment for persons with co-
occurring disorders. Rockville, MD: Substance Abuse and Mental Health Services
Administration (SAMHSA).
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C. CSAT (2004a) Center for Substance Abuse Treatment. (2004). Substance abuse treatment: group therapy.
Rockville, MD: Substance Abuse and Mental Health Services Administration.
D. CSAT (2004b) Center for Substance Abuse Treatment. (2004). Substance abuse treatment and family therapy.
Rockville, MD: Substance Abuse and Mental Health Services Administration.
E. MQIC (2003) Michigan Quality Improvement Consortium. (2005, Aug). Screening and management of
substance use disorders. Southfield,(MI: Michigan Quality Improvement Consortium.
F. NYSDH (2005) New York State Department of Health. (2005, Mar). Screening and ongoing assessment for
substance use. New York, NY: New York State Department of Health.
G. NYSDH (2006) New York State Department of Health. (2006, Oct). Working with the active user. New York,
NY: New York State Department of Health.
H. SAMHSA (2005) Peters RH, Wexler HK. (2005 Sep 12). Substance abuse treatment for adults in the criminal
justice system. Rockville, MD: Substance Abuse and Mental Health Services Administration
(SAMHSA).
I. USPSTF (2004) Screening and behavioral counseling interventions in primary care to reduce alcohol misuse:
recommendations statement. Ann Intern Med (2004, Apr 6);140(7):554–556.
Bipolar disorder
J. APA (2002) Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry
(2002 Apr); 159(4 Suppl):1–50.
Major depressive disorder
K. AMDA (2003) American Medical Directors Association (AMDA). (2003). Depression. Columbia, MD:
American Medical Directors Association (AMDA).
L. APA (2000) American Psychiatric Association practice guideline for the treatment of patients with major
depressive disorder. Am J Psychiatry (2000 Apr);157(4 Suppl):1–45.
M. ICSI (2004) Institute for Clinical Systems Improvement (ICSI). (2006, May). Major depression in adults in
primary care. Bloomington, MN: Institute for Clinical Systems Improvement (ICSI).
N. KPCMI (2006) Kaiser Permanente Care Management Institute. (2006, Mar). Depression clinical practice
guidelines. Oakland, CA: Kaiser Permanente Care Management Institute.
O. MQIC (2006) Michigan Quality Improvement Consortium. (2006, Jan). Management of adults with major
depression. Southfield, MI: Michigan Quality Improvement Consortium.
P. UMHS (2004) University of Michigan Health System. (2005 Oct). Depression. Ann Arbor, MI: University of
Michigan Health System.
Q. USPSTF (2002) US Preventive Services Task Force. Screening for depression: recommendations and rationale.
Ann Intern Med (2002, May 21);136(10):760–764.
S. VA/DoD (2004) Veterans Administration, Department of Defense. (2004, May). Management of persons with
psychoses. Washington, DC: Department of Veteran Affairs.
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